Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

Warrants (Tables)

3 Months Ended

Mar. 31, 2014

A summary of outstanding common stock warrants at March 31, 2014 is as follows:

	Number of		Exercise		Expiration
Security	warrants		price/share		date
Former Series E redeemable convertible preferred stock warrants		4,222	$	9.612	2017
Common stock		161,295		0.300	2017-2019
		165,517

A summary of outstanding warrants at December 31, 2013 is as follows:

	Number of		Exercise		Expiration
Security	warrants		price/share		date
Series C redeemable convertible preferred stock warrants		14,215	$	17.580	2015
Series D redeemable convertible preferred stock warrants		11,415		21.900	2013-2014
Series E redeemable convertible preferred stock warrants		3,120		9.612	2015
Series E redeemable convertible preferred stock warrants		1,102		9.612	2016
Common stock		233,611		0.300	2017-2019
		263,463

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details